University of Minnesota. Driven to Discover.
Cases have now reached 626 and could soon top the ignomious post-elimination record of 667, reached in 2014.
Panel gives a preference to Shingrix and recommends MMR for mumps outbreaks.
ACIP spent several months reviewing clinical trial data that showed two doses in younger adolescents prompted an immune response similar to or higher than in young adults.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.